New patent for Janssen Pharms drug INVEGA HAFYERA – DrugPatentWatch
Annual Drug Patent Expiration for INVEGA+HAFYERA
Invega Hafyera is a drug marketed by Janssen Pharms and included in one NDA. It is available from a single supplier. There are two patents protecting this drug.
This drug has six patent family members in three countries.
The generic ingredients in INVEGA HAFYERA are paliperidone palmitate. One registered supplier for this compound. Additional details are available on the paliperidone palmitate profile page.
For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact admin@DrugPatentWatch.com or visit www.DrugPatentWatch.com
Make Better Decisions with DrugPatentWatch
» Start Your Free Trial Today «
Copyright © DrugPatentWatch. Originally published in New patent for the Janssen Pharms drug INVEGA HAFYERA
